Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist commonly studied in metabolic research involving incretin signalling, glucose regulation, insulin response, energy balance and appetite-related pathways. Lianhua Peptide Co. — Hangzhou · Zhejiang · China — supplies Tirzepatide for laboratory research with cGMP manufacturing standards, >98% purity specifications, HPLC-MS quality analysis, practical box ordering and tracked international fulfilment.

For laboratory and research use only. Not for human or animal consumption.